All Aiforia’s financial reports and presentation materials can be found here. We publish financial reports half-yearly. The dates of publications are available on our Investor Calendar.
2023
October 24, 2023
Aiforia’s CEO Jukka Tapaninen was interviewed by Inderes Equity Research Analyst on company’s recent development.
September 12, 2023
Aiforia's CEO Jukka Tapaninen talked about the future of AI in pathology and Aiforia's plans for growth.
August 30, 2023
Aiforia's CEO Jukka Tapaninen presented at Pörssin Avoimet Ovet, an open house event hosted by Nasdaq Helsinki.
August 25, 2023
Aiforia’s CEO Jukka Tapaninen was interviewed by Inderes Equity Research Analyst on the company’s results in first half of 2023.
August 25, 2023
Key openings in the clinical diagnostics market – strong growth in the order book.
May 08, 2023
Aiforia’s CEO Jukka Tapaninen was interviewed by Inderes Equity Research Analyst on company’s recent development.
April 19, 2023
Aiforia's CEO Jukka Tapaninen presented at Carnegie Nordic Virtual Healthtech Seminar.
March 30, 2023
Aiforia's CEO Jukka Tapaninen presented company's results from financial year 2022 at Annual General Meeting 2023.
March 30, 2023
Aiforia's COO Kaisa Helminen presented at Redeye Future of Healthcare Seminar.
March 22, 2023
Aiforia's COO Kaisa Helminen was speaking at Swedbank Finnish Life Science event about Aiforia.
March 2, 2023
Aiforia's CEO Jukka Tapaninen was interviewed by Inderes Oyj Equity Research Analyst on company's results in 2022 and current priorities.
2022
09/03/2023
The Financial Statements consist of the consolidated as well as the parent company’s financial statements and auditor’s report.
02/03/2023
Growth continues, driven by the development of the clinical market
13/12/2022
01/12/2022
27/09/2022
13/09/2022
25/08/2022
23/05/2022